Book a Meeting

Anti-Lymphotoxin alpha Antibody, Non-Fucosylated (BioBet-1191ZP)

Cat#: BioBet-1191ZP
Target: Lymphotoxin alpha
Isotype: IgG
Host: Human
Species Reactivity: Human

Description Anti-Lymphotoxin alpha Antibody, Non-Fucosylated (BioBet-1191ZP) is a human monoclonal IgG antibody against Lymphotoxin alpha. This product is an ADCC enhanced antibody produced by our Afuco™ platform.

Antibody Indication Inflammatory Diseases; Autoimmune Diseases

Classification Therapeutic antibody; biobetter

Cooperation Seeking Creative Biolabs is interested in collaborating with potential partners (include but not limit to major pharma or biotech firms) to further co-develop ADCC-enhanced Lymphotoxin alpha antibody. For commercial partners interested in our ADCC-enhanced therapeutic antibodies, Creative Biolabs welcomes collaboration. Here are two ways for your choice, and please contact us for more details.
1) Collaborate with us and co-develop the programs from discovery phase to IND enabling. Costs will be shared.
2) Become a licensed candidate of our programs.
Looking forward to cooperating with you in the near future.

Official Name LTA

Full Name lymphotoxin alpha

Background The encoded protein, a member of the tumor necrosis factor family, is a cytokine produced by lymphocytes. The protein is highly inducible, secreted, and forms heterotrimers with lymphotoxin-beta which anchor lymphotoxin-alpha to the cell surface. This protein also mediates a large variety of inflammatory, immunostimulatory, and antiviral responses, is involved in the formation of secondary lymphoid organs during development and plays a role in apoptosis. Genetic variations in this gene are associated with susceptibility to leprosy type 4, myocardial infarction, non-Hodgkins lymphoma, and psoriatic arthritis. Alternatively spliced transcript variants have been observed for this gene.

Alternative Names LTA; lymphotoxin alpha; LT; TNFB; TNFSF1; lymphotoxin-alpha; LT-alpha; TNF-beta; TNF superfamily, member 1; tumor necrosis factor beta; tumor necrosis factor ligand superfamily member 1

Gene ID 4049

Cellular Localization Extracellular region or secreted

Involvement in Disease Diseases associated with LTA include Psoriatic Arthritis and Leprosy 4.

Related Pathways Its related pathways are Apoptosis Modulation and Signaling and NF-KappaB Family Pathway.

Function A trimeric cytokine that binds to TNFRSF1A/TNFR1, TNFRSF1B/TNFBR and TNFRSF14/HVEM. It binds to TNFRSF3/LTBR in the form of heterotrimer with LTB. Lymphotoxins are produced by lymphocytes and are cytotoxic to a variety of tumor cells in vivo and in vitro.

Field of research Cell Biology and Cellular Response antibody; Developmental Biology antibody; Neuroscience antibody; Signaling Transduction antibody

Post-translational modifications Phosphorylation at Ser-416 inhibits enzymatic activity.

Biologic Classification Protein Based Therapies
Monoclonal antibody (mAb)

Antibody Isotype IgG

Antibody Clone BioBet-1191ZP

Description The antibody, including specified portions or variants, specific for at least one human lymphotoxin alpha (LTα) protein, have been implicated in inflammatory diseases, autoimmune diseases, viral, bacterial and parasitic infections, malignancies, and/or neurogenerative diseases.

Antibody Indication Inflammatory Diseases; Autoimmune Diseases

Inflammatory Diseases; Autoimmune Diseases

All products and services are for Research Use Only. Do Not use in humans.

ONLINE INQUIRY

Creative Biolabs has established a team of customer support scientists ready to discuss ADCC/CDC optimization strategies, antibody production, bioinformatics analysis and other molecular biology/biotechnology issues.

  • *
  • *

ISO 9001 Certified - Creative Biolabs Quality Management System.
© 2026 Creative Biolabs. All rights reserved.
Merry Christmas Merry Christmas